Scientific Presentation

COVID-19 lab safety considerations when re-opening the lab
Will Oldham, Christine Scherp, MD
Description
While California has extended its shelter-in-place order through the end of May, some San Francisco, Bay Area laboratories might be permitted to re-open in a few weeks. As we think about preparing to re-activate Mission Bio operations, when state clearance is provided and it is safe to do so, there are numerous things to consider when reinstating a lab while adhering to safety and health guidelines. Join a discussion with our leaders from Manufacturing and Quality to hear about some of the things we are considering before we re-open our labs.
SHARE THIS PAGE
Scientific Presentations

Interrogating Clonal Evolution in Acute Leukemias through Single-Cell Multi-omic (DNA+Fusion and DNA+Immunophenotype) Analysis
Morgan Drucker, MD
(2025)
Scientific Presentations

Epitope Editing in Hematopoietic Cells Enables Protection From CD45-directed Immunotherapies For The Treatment Of Blood Cancers And HIV Reservoir Elimination
Dr. Nils Wellhausen
(2025)
Scientific Presentations

Leverage Single-cell Multi-parametric Datasets to Advance Heme Oncology Pipelines
Azad Gucwa, PhD
14th World Clinical Biomarkers & Companion Diagnostics Summit (2024)
Scientific Presentations

DKFZ Seminar: Subclonal evolution over the course of quadruplet induction in transplant eligible MM patients
Céline Mazzotti
(2024)